Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS

Publication: Neurology

Arnold DL, Fisher E, Brinar VV, Cohen JA, Coles AJ, Giovannoni G, Hartung HP, Havrdova E, Selmaj KW, Stojanovic M, Weiner HL, Lake SL, Margolin DH, Thomas DR, Panzara MA, Compston DA; CARE-MS I and CARE-MS II Investigators

4 October 2016

View publication

© Copyright - NIHR Cambridge Biomedical Research Centre 2025